17 July 2026: An extraordinary general meeting of Aker BioMarine ASA will be
held on 17 August 2026 at 09:00 CEST.
The meeting will be conducted as a virtual meeting only, and voting will be
handled online during the meeting. Information about log-in details for the
meeting is available in the notice of the general meeting. For further
information regarding participation, please go to www.akerbiomarine/agm.
No pre-registration is needed for attending online, but attendees must be logged
in before the meeting starts. Deadline for registration of advance votes and
proxies is 14 August 2026 at 16:00 CEST.
Please find attached the following documents
- Notice and Proxy forms for the Extraordinary General Meeting
- Proposed Resolutions for the Extraordinary General Meeting
All documents to be processed in the meeting are available on
www.akerbiomarine/agm.
For further information, please contact
Lars Jacobsen, General Counsel
Mobile: +47 906 05 306
Email: lars.jacobsen@akerbiomarine.com
This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act.
About Aker BioMarine
Aker BioMarine is a leading human health and nutrition innovator that develops
krill-derived products for consumer health and nutrition. Krill is a natural,
powerful, and health-promoting source of nutrients from the pristine waters of
Antarctica, and Aker BioMarine has a unique position in its industry. The
ingredient portfolio consists of Superba Krill Oil, Lysoveta, Revervia, and PL+,
as well as the consumer brand, Kori Krill. The innovative approach also extends
into the spin-offs AION (reduce and recycle plastic waste across industries) and
Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock
Exchange (AKBM). More information is available at www.akerbiomarine.com.
information is available at www.akerbiomarine.com. \